The hsp90 inhibitor, 17-AAG, prevents the ligand-lndependent nuclear localization of androgen receptor in refractory prostate cancer cells

The hsp90 inhibitor, 17-AAG, prevents the ligand-lndependent nuclear localization of androgen receptor in refractory prostate cancer cells

Saved in:
Bibliographic Details
Published in:The Prostate Vol. 67; no. 5; pp. 509 - 520
Main Authors: SAPORITA, Anthony J, JUNKUI AI, ZHOU WANG
Format: Journal Article
Language:English
Published: New York, NY Wiley-Liss 2007
Subjects:
Biological and medical sciences
Gynecology. Andrology. Obstetrics
Male genital diseases
Medical sciences
Nephrology. Urinary tract diseases
Tumors
Tumors of the urinary system
Urinary tract. Prostate gland
Andrology
Nuclear receptor
Nephrology
Prostate disease
Ligand
Prevention
Hsp90
Heat shock protein
Localization
androgen-independence
Male genital diseases
Tumor cell
Heat shock protein 90
Treatment resistance
Urinary system disease
Androgen
intracellular localization
Gynecology
Independence
Malignant tumor
Refractory
Androgen receptor
Inhibitor
Intracellular
Sex steroid hormone
Prostate cancer
Hormonal receptor
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0270-4137
1097-0045